Romano Brothers & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.7M | Sell |
6,032
-18
| -0.3% | -$14K | 0.58% | 48 |
|
2025
Q1 | $5M | Buy |
6,050
+531
| +10% | +$439K | 0.65% | 47 |
|
2024
Q4 | $4.26M | Sell |
5,519
-7
| -0.1% | -$5.4K | 0.54% | 54 |
|
2024
Q3 | $4.9M | Buy |
5,526
+37
| +0.7% | +$32.8K | 0.61% | 48 |
|
2024
Q2 | $4.97M | Buy |
5,489
+29
| +0.5% | +$26.3K | 0.69% | 41 |
|
2024
Q1 | $4.25M | Sell |
5,460
-263
| -5% | -$205K | 0.58% | 52 |
|
2023
Q4 | $3.34M | Sell |
5,723
-330
| -5% | -$192K | 0.5% | 65 |
|
2023
Q3 | $3.25M | Buy |
6,053
+112
| +2% | +$60.2K | 0.51% | 64 |
|
2023
Q2 | $2.79M | Buy |
5,941
+65
| +1% | +$30.5K | 0.42% | 80 |
|
2023
Q1 | $2.02M | Buy |
5,876
+1,456
| +33% | +$500K | 0.31% | 99 |
|
2022
Q4 | $1.62M | Sell |
4,420
-1,000
| -18% | -$366K | 0.25% | 107 |
|
2022
Q3 | $1.75M | Buy |
+5,420
| New | +$1.75M | 0.28% | 102 |
|